A. Albada, M. Vernooij, L. Van-osch, A. Pijpe, S. Van-dulmen et al., Does and should breast cancer genetic counselling include lifestyle advice?, Familial Cancer, vol.13, pp.35-44, 2014.

N. Amara, J. Blouin-bougie, J. Jbilou, N. Halilem, J. Simard et al., The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes, Familial Cancer, vol.15, issue.1, pp.1-17, 2015.

E. Amir, O. C. Freedman, B. Seruga, and D. G. Evans, Assessing women at high risk of breast cancer: a review of risk assessment models, J Natl Cancer Inst, vol.102, pp.680-691, 2010.

A. C. Antoniou, P. P. Pharoah, P. Smith, and D. F. Easton, The BOADICEA model of genetic susceptibility to breast and ovarian cancer, Br J Cancer, vol.91, pp.1580-1590, 2004.

A. C. Antoniou, R. Hardy, L. Walker, D. G. Evans, A. Shenton et al., Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics, J Med Genet, vol.45, pp.425-431, 2008.

A. Bredart, J. L. Kop, A. C. Antoniou, A. P. Cunningham, D. Pauw et al., Use of the BOADICEA web application in clinical practice: appraisals by clinicians from various countries, Familial Cancer, vol.17, issue.1, pp.31-41, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02275380

A. R. Brentnall, E. F. Harkness, S. M. Astley, L. S. Donnelly, P. Stavrinos et al., Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort, Breast Cancer Res, vol.17, issue.1, p.147, 2015.

J. A. Cintolo-gonzalez, D. Braun, A. L. Blackford, E. Mazzola, A. Acar et al., Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications, Breast Cancer Res Treat, vol.164, issue.2, pp.263-284, 2017.

E. B. Claus, N. Risch, and W. D. Thompson, Genetic analysis of breast cancer in the cancer and steroid hormone study, Am J Hum Genet, vol.48, pp.232-242, 1991.

E. Cottrell, E. Roddy, T. Rathod, E. Thomas, M. Porcheret et al., Maximising response from GPs to questionnaire surveys: do length or incentives make a difference, BMC Med Res Methodol, vol.15, p.3, 2015.

F. J. Couch, K. L. Nathanson, and K. Offit, Two decades after BRCA: setting paradigms in personalized cancer care and prevention, Science, vol.343, pp.1466-1470, 2014.

A. P. Cunningham, A. C. Antoniou, and D. F. Easton, Clinical software development for the web: lessons learned from the BOADICEA project, BMC Med Inform Decis Mak, vol.12, p.30, 2012.

J. Cuzick, A. R. Brentnall, C. Segal, H. Byers, C. Reuter et al., Impact of a panel of 88 single nucleotide polymorphisms on the risk of breast cancer in high-risk women: results from two randomized tamoxifen prevention trials, J Clin Oncol, vol.35, issue.7, pp.743-750, 2016.

C. E. Desantis, F. Bray, J. Ferlay, J. Lortet-tieulent, B. O. Anderson et al., International variation in female breast cancer incidence and mortality rates, Cancer Epidemiol Biomark Prev, vol.24, pp.1495-1506, 2015.

D. F. Easton, P. D. Pharoah, A. C. Antoniou, M. Tischkowitz, S. V. Tavtigian et al., Gene-panel sequencing and the prediction of breast-cancer risk, N Engl J Med, vol.372, pp.2243-2257, 2015.

P. J. Edwards, I. Roberts, M. J. Clarke, C. Diguiseppi, R. Wentz et al., Methods to increase response to postal and electronic questionnaires, Cochrane Database Syst Rev, vol.8, issue.3, p.8, 2009.

D. G. Evans, D. M. Eccles, N. Rahman, K. Young, M. Bulman et al., A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO, J Med Genet, vol.41, pp.474-480, 2004.

D. G. Evans, F. Lalloo, A. Wallace, and N. Rahman, Update on the Manchester scoring system for BRCA1 and BRCA2 testing, J Med Genet, vol.42, issue.7, p.39, 2005.

D. G. Evans and A. Howell, Breast cancer risk-assessment models, Breast Cancer Res, vol.9, issue.5, p.213, 2007.

T. S. Frank, A. M. Deffenbaugh, J. E. Reid, M. Hulick, B. E. Ward et al., Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals, J Clin Oncol, vol.20, pp.1480-1490, 2002.

M. H. Gail, L. A. Brinton, D. P. Byar, D. K. Corle, S. B. Green et al., Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J Natl Cancer Inst, vol.81, pp.1879-1886, 1989.

M. Harvie, A. Howell, and D. G. Evans, Can diet and lifestyle prevent breast cancer: what is the evidence?, Am Soc Clin Oncol Educ Book, vol.35, pp.66-73, 2015.

F. Husson, S. Lê, J. Pagès, C. Julian-reynier, A. D. Bouhnik et al., and the UK show variable breast cancer risk communication profiles, General practitioners and breast surgeons in, vol.15, p.243, 2002.

A. W. Kurian, A. C. Antoniou, and S. M. Domchek, Refining breast cancer risk stratification: additional genes, additional information, Am Soc Clin Oncol Educ Book, vol.35, pp.44-56, 2016.

J. Lecarpentier, C. Nogues, E. Mouret-fourme, B. Buecher, M. Gauthiervillars et al.,

O. Caron, I. Coupier, P. Pujol, L. Faivre, P. Gesta et al., Breast cancer risk associated with estrogen exposure and truncating mutation location in BRCA1/2 carriers, Cancer Epidemiol Biomark Prev, vol.24, pp.698-707, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01990932

A. J. Lee, A. P. Cunningham, K. B. Kuchenbaecker, N. Mavaddat, D. F. Easton et al., BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, Br J Cancer, vol.110, pp.535-545, 2014.

A. J. Lee, A. P. Cunningham, M. Tischkowitz, J. Simard, P. D. Pharoah et al., Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model, Genet Med, vol.18, pp.1190-1198, 2016.

C. Limesurvey-project-team and . Schmitz, LimeSurvey: an open source survey tool, 2015.

R. J. Macinnis, A. Bickerstaffe, C. Apicella, G. S. Dite, J. G. Dowty et al., Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre, Br J Cancer, vol.109, pp.1296-1301, 2013.

E. Mazzola, A. Blackford, G. Parmigiani, and S. Biswas, Recent enhancements to the genetic risk prediction model BRCAPRO, Cancer Inform, vol.14, pp.147-157, 2015.

C. Meads, I. Ahmed, and R. D. Riley, A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance, Breast Cancer Res Treat, vol.132, pp.365-377, 2012.

T. J. Padamsee, C. E. Wills, L. D. Yee, and E. D. Paskett, Decision making for breast cancer prevention among women at elevated risk, Breast Cancer Res, vol.19, p.34, 2017.

G. Parmigiani, D. Berry, and O. Aguilar, Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2, Am J Hum Genet, vol.62, pp.145-158, 1998.

G. Parmigiani, S. Chen, E. S. Iversen, T. M. Friebel, D. M. Finkelstein et al., Validity of models for predicting BRCA1 and BRCA2 mutations, Ann Intern Med, vol.147, pp.441-450, 2007.

A. S. Quante, A. S. Whittemore, T. Shriver, K. Strauch, and M. B. Terry, Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance, Breast Cancer Res, vol.14, issue.6, p.144, 2012.

A. S. Quante, J. Herz, A. S. Whittemore, C. Fischer, K. Strauch et al., Assessing absolute changes in breast cancer risk due to modifiable risk factors, Breast Cancer Res Treat, vol.152, pp.193-197, 2015.

. R-core-team, R: a language and environment for statistical computing, R Foundation for Statistical Computing, 2016.

D. Shattuck-eidens, A. Oliphant, M. Mcclure, C. Mcbride, J. Gupte et al., BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing, JAMA, vol.278, pp.1242-1250, 1997.

B. G. Tabachnick and L. S. Fidell, Using multivariate statistics, 6th edn, 2013.

J. Tyrer, S. W. Duffy, and J. Cuzick, A breast cancer prediction model incorporating familial and personal risk factors, Stat Med, vol.23, p.1111, 2004.